0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-34G12902
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Flu Vaccination Market Research Report 2023
BUY CHAPTERS

Global Flu Vaccination Market Research Report 2025

Code: QYRE-Auto-34G12902
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Flu Vaccination Market Size

The global market for Flu Vaccination was valued at US$ 8853 million in the year 2024 and is projected to reach a revised size of US$ 12640 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Flu Vaccination Market

Flu Vaccination Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccination.
The Flu Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Flu Vaccination Market Report

Report Metric Details
Report Name Flu Vaccination Market
Accounted market size in year US$ 8853 million
Forecasted market size in 2031 US$ 12640 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 6 Months to 3 Years
  • Above 3 Years
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Flu Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Flu Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Flu Vaccination Market growing?

Ans: The Flu Vaccination Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Flu Vaccination Market size in 2031?

Ans: The Flu Vaccination Market size in 2031 will be US$ 12640 million.

Who are the main players in the Flu Vaccination Market report?

Ans: The main players in the Flu Vaccination Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Flu Vaccination Market report?

Ans: The Applications covered in the Flu Vaccination Market report are 6 Months to 3 Years, Above 3 Years

What are the Type segmentation covered in the Flu Vaccination Market report?

Ans: The Types covered in the Flu Vaccination Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

Recommended Reports

Vaccine Types

Vaccine Delivery

Influenza Markets

1 Flu Vaccination Market Overview
1.1 Product Definition
1.2 Flu Vaccination by Type
1.2.1 Global Flu Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccination by Application
1.3.1 Global Flu Vaccination Market Value by Application (2024 VS 2031)
1.3.2 6 Months to 3 Years
1.3.3 Above 3 Years
1.4 Global Flu Vaccination Market Size Estimates and Forecasts
1.4.1 Global Flu Vaccination Revenue 2020-2031
1.4.2 Global Flu Vaccination Sales 2020-2031
1.4.3 Global Flu Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Flu Vaccination Market Competition by Manufacturers
2.1 Global Flu Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Flu Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Flu Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Flu Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flu Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flu Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Flu Vaccination, Date of Enter into This Industry
2.8 Global Flu Vaccination Market Competitive Situation and Trends
2.8.1 Global Flu Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Flu Vaccination Players Market Share by Revenue
2.8.3 Global Flu Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Flu Vaccination Market Scenario by Region
3.1 Global Flu Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Flu Vaccination Sales by Region: 2020-2031
3.2.1 Global Flu Vaccination Sales by Region: 2020-2025
3.2.2 Global Flu Vaccination Sales by Region: 2026-2031
3.3 Global Flu Vaccination Revenue by Region: 2020-2031
3.3.1 Global Flu Vaccination Revenue by Region: 2020-2025
3.3.2 Global Flu Vaccination Revenue by Region: 2026-2031
3.4 North America Flu Vaccination Market Facts & Figures by Country
3.4.1 North America Flu Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Flu Vaccination Sales by Country (2020-2031)
3.4.3 North America Flu Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Flu Vaccination Market Facts & Figures by Country
3.5.1 Europe Flu Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Flu Vaccination Sales by Country (2020-2031)
3.5.3 Europe Flu Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Flu Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Flu Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Flu Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flu Vaccination Market Facts & Figures by Country
3.7.1 Latin America Flu Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Flu Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Flu Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Flu Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Flu Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flu Vaccination Sales by Type (2020-2031)
4.1.1 Global Flu Vaccination Sales by Type (2020-2025)
4.1.2 Global Flu Vaccination Sales by Type (2026-2031)
4.1.3 Global Flu Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Flu Vaccination Revenue by Type (2020-2031)
4.2.1 Global Flu Vaccination Revenue by Type (2020-2025)
4.2.2 Global Flu Vaccination Revenue by Type (2026-2031)
4.2.3 Global Flu Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Flu Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Flu Vaccination Sales by Application (2020-2031)
5.1.1 Global Flu Vaccination Sales by Application (2020-2025)
5.1.2 Global Flu Vaccination Sales by Application (2026-2031)
5.1.3 Global Flu Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Flu Vaccination Revenue by Application (2020-2031)
5.2.1 Global Flu Vaccination Revenue by Application (2020-2025)
5.2.2 Global Flu Vaccination Revenue by Application (2026-2031)
5.2.3 Global Flu Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Flu Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Flu Vaccination Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Flu Vaccination Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Flu Vaccination Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Flu Vaccination Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Flu Vaccination Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Flu Vaccination Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Flu Vaccination Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Flu Vaccination Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Flu Vaccination Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Flu Vaccination Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Flu Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Flu Vaccination Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu Vaccination Industry Chain Analysis
7.2 Flu Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu Vaccination Production Mode & Process Analysis
7.4 Flu Vaccination Sales and Marketing
7.4.1 Flu Vaccination Sales Channels
7.4.2 Flu Vaccination Distributors
7.5 Flu Vaccination Customer Analysis
8 Flu Vaccination Market Dynamics
8.1 Flu Vaccination Industry Trends
8.2 Flu Vaccination Market Drivers
8.3 Flu Vaccination Market Challenges
8.4 Flu Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Flu Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Flu Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Flu Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Flu Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Flu Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Flu Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Flu Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Flu Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Flu Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Flu Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Flu Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Flu Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Flu Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Flu Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Flu Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Flu Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Flu Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Flu Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Flu Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Flu Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Flu Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Flu Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Flu Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Flu Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Flu Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Flu Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Flu Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Flu Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Flu Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Flu Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Flu Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Flu Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Flu Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Flu Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Flu Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Flu Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Flu Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Flu Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Flu Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Flu Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Flu Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Flu Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Flu Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Flu Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Flu Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Flu Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Flu Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Flu Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Flu Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Flu Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Flu Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Flu Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Flu Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Flu Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Flu Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Flu Vaccination Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Flu Vaccination Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Flu Vaccination Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Viatris Flu Vaccination Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Flu Vaccination Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hualan Bio Flu Vaccination Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Changchun Institute of Biological Company Information
 Table 101. Changchun Institute of Biological Description and Business Overview
 Table 102. Changchun Institute of Biological Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Changchun Institute of Biological Flu Vaccination Product
 Table 104. Changchun Institute of Biological Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Flu Vaccination Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. BCHT Company Information
 Table 111. BCHT Description and Business Overview
 Table 112. BCHT Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BCHT Flu Vaccination Product
 Table 114. BCHT Recent Developments/Updates
 Table 115. Jiangsu GDK Company Information
 Table 116. Jiangsu GDK Description and Business Overview
 Table 117. Jiangsu GDK Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jiangsu GDK Flu Vaccination Product
 Table 119. Jiangsu GDK Recent Developments/Updates
 Table 120. KM Biologics Company Information
 Table 121. KM Biologics Description and Business Overview
 Table 122. KM Biologics Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. KM Biologics Flu Vaccination Product
 Table 124. KM Biologics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Flu Vaccination Distributors List
 Table 128. Flu Vaccination Customers List
 Table 129. Flu Vaccination Market Trends
 Table 130. Flu Vaccination Market Drivers
 Table 131. Flu Vaccination Market Challenges
 Table 132. Flu Vaccination Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Flu Vaccination
 Figure 2. Global Flu Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Flu Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Trivalent Influenza Vaccine Product Picture
 Figure 5. Quadrivalent Influenza Vaccine Product Picture
 Figure 6. Global Flu Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Flu Vaccination Market Share by Application: 2024 & 2031
 Figure 8. 6 Months to 3 Years
 Figure 9. Above 3 Years
 Figure 10. Global Flu Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Flu Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Flu Vaccination Sales (2020-2031) & (K Units)
 Figure 13. Global Flu Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 14. Flu Vaccination Report Years Considered
 Figure 15. Flu Vaccination Sales Share by Manufacturers in 2024
 Figure 16. Global Flu Vaccination Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Flu Vaccination Players: Market Share by Revenue in Flu Vaccination in 2024
 Figure 18. Flu Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Flu Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Flu Vaccination Sales Market Share by Country (2020-2031)
 Figure 21. North America Flu Vaccination Revenue Market Share by Country (2020-2031)
 Figure 22. United States Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Flu Vaccination Sales Market Share by Country (2020-2031)
 Figure 25. Europe Flu Vaccination Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Flu Vaccination Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Flu Vaccination Revenue Market Share by Region (2020-2031)
 Figure 33. China Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Flu Vaccination Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Flu Vaccination Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Flu Vaccination Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Flu Vaccination Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Flu Vaccination by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Flu Vaccination by Type (2020-2031)
 Figure 54. Global Flu Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Flu Vaccination by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Flu Vaccination by Application (2020-2031)
 Figure 57. Global Flu Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 58. Flu Vaccination Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India